ROSSARI Stock Overview
Engages in manufacture and sale of specialty chemicals in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for ROSSARI from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Rossari Biotech Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹784.95 |
| 52 Week High | ₹972.70 |
| 52 Week Low | ₹656.95 |
| Beta | 0.27 |
| 1 Month Change | 1.24% |
| 3 Month Change | -16.64% |
| 1 Year Change | -1.38% |
| 3 Year Change | -37.12% |
| 5 Year Change | n/a |
| Change since IPO | 5.84% |
Recent News & Updates
Recent updates
Why We Think Rossari Biotech Limited's (NSE:ROSSARI) CEO Compensation Is Not Excessive At All
Aug 17
Is Rossari Biotech (NSE:ROSSARI) Using Too Much Debt?
Jun 14Rossari Biotech's (NSE:ROSSARI) Solid Profits Have Weak Fundamentals
May 07Analyst Estimates: Here's What Brokers Think Of Rossari Biotech Limited (NSE:ROSSARI) After Its Annual Report
May 03One Analyst Just Shaved Their Rossari Biotech Limited (NSE:ROSSARI) Forecasts Dramatically
Feb 10Returns On Capital At Rossari Biotech (NSE:ROSSARI) Paint A Concerning Picture
Sep 23Returns On Capital Signal Tricky Times Ahead For Rossari Biotech (NSE:ROSSARI)
Apr 06Need To Know: Analysts Are Much More Bullish On Rossari Biotech Limited (NSE:ROSSARI) Revenues
Feb 19Rossari Biotech Limited Just Beat Revenue Estimates By 6.8%
Feb 17I Ran A Stock Scan For Earnings Growth And Rossari Biotech (NSE:ROSSARI) Passed With Ease
Feb 10Capital Allocation Trends At Rossari Biotech (NSE:ROSSARI) Aren't Ideal
Nov 24With EPS Growth And More, Rossari Biotech (NSE:ROSSARI) Is Interesting
Oct 12Is Rossari Biotech Limited's (NSE:ROSSARI) Latest Stock Performance Being Led By Its Strong Fundamentals?
Dec 17Rossari Biotech (NSE:ROSSARI) Is Growing Earnings But Are They A Good Guide?
Oct 26
Shareholder Returns
| ROSSARI | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | -3.0% | -4.7% | -4.2% |
| 1Y | -1.4% | 4.7% | 19.4% |
Return vs Industry: ROSSARI underperformed the Indian Chemicals industry which returned 4.7% over the past year.
Return vs Market: ROSSARI underperformed the Indian Market which returned 19.4% over the past year.
Price Volatility
| ROSSARI volatility | |
|---|---|
| ROSSARI Average Weekly Movement | 4.7% |
| Chemicals Industry Average Movement | 5.8% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: ROSSARI has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: ROSSARI's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 450 | Sunil Chari | www.rossari.com |
Rossari Biotech Limited engages in manufacture and sale of specialty chemicals in India and internationally. It offers soap and detergents; inks, paints, and coatings; ceramics and tiles; pulp and papers; cement; performance additives; and water treatment solutions. The company also provides textile specialty chemicals, such as cotton, polyester, acrylic, wool, silk, nylon, functional finishes, denim, printing, and sustainable solutions; and pet grooming products, which include natural pet shampoos, powders, deodorants, sprays, creams, and floor washing liquids under the Lozalo, Hunger Fills, and Sniffy brand names.
Rossari Biotech Limited Fundamentals Summary
| ROSSARI fundamental statistics | |
|---|---|
| Market cap | ₹43.45b |
| Earnings (TTM) | ₹1.39b |
| Revenue (TTM) | ₹19.24b |
31.3x
P/E Ratio2.3x
P/S RatioIs ROSSARI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ROSSARI income statement (TTM) | |
|---|---|
| Revenue | ₹19.24b |
| Cost of Revenue | ₹13.50b |
| Gross Profit | ₹5.74b |
| Other Expenses | ₹4.36b |
| Earnings | ₹1.39b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 25.07 |
| Gross Margin | 29.85% |
| Net Profit Margin | 7.21% |
| Debt/Equity Ratio | 12.8% |
How did ROSSARI perform over the long term?
See historical performance and comparisonDividends
0.06%
Current Dividend Yield2%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 18:22 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Rossari Biotech Limited is covered by 5 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Anand Rathi Shares and Stock Brokers Limited |
| Bhawana Israni | Anand Rathi Shares and Stock Brokers Limited |
| Rohit Nagraj | Centrum Broking Limited |